Mette Aldahl1,2, Anne-Sofie Caroline Jensen1,2, Line Davidsen1,2, Matilde Alida Eriksen1, Steen Møller Hansen3, Berit Jamie Nielsen3, Maria Lukács Krogager1,2, Lars Køber4, Christian Torp-Pedersen1,3, Peter Søgaard5. 1. Department of Health, Science and Technology, Aalborg University, Fredrik Bajers Vej 7 D2, 9220 Aalborg East, Denmark. 2. Department of Cardiology and Clinical Epidemiology, Aalborg University Hospital, Hobrovej 18-22 and Søndre Skovvej 15, 9000 Aalborg, Denmark. 3. Department of Clinical Epidemiology, Aalborg University Hospital, Søndre Skovvej 15, 9000 Aalborg, Denmark. 4. Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. 5. Department of Cardiology and Clinical Medicine Center for Cardiovascular Research, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
Abstract
AIMS: Medication prescribed to patients suffering from chronic heart failure carries an increased risk of impaired potassium homeostasis. We examined the relation between different levels of serum potassium and mortality among patients with chronic heart failure. METHODS AND RESULTS: From Danish National registries, we identified 19 549 patients with a chronic heart failure diagnosis who had a measurement of potassium within minimum 90 days after initiated medical treatment with loop diuretics and angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers. All-cause mortality was examined according to eight predefined potassium levels: 2.8-3.4 mmol/L, 3.5-3.8 mmol/L, 3.9-4.1 mmol/L, 4.2-4.4 mmol/L, 4.5-4.7 mmol/L, 4.8-5.0 mmol/L, 5.1-5.5 mmol/L, and 5.6-7.4 mmol/L. Follow-up was 90 days from potassium measurement. We estimated the risk of all-cause mortality using multivariable adjusted Cox proportional hazard model, with normal serum potassium level at 4.2-4.4 mmol/L as reference. After 90 days, the mortality in the eight strata was 14.4, 8.0, 6.3, 5.0, 5.8, 7.9, 10.3, and 21.1% respectively. In multivariable adjusted analysis, patients with potassium levels of 2.8-3.4 mmol/L [hazard ratio (HR): 3.16; confidence interval (CI): 2.43-4.11], 3.5-3.8 mmol/L (HR: 1.62; CI: 1.31-1.99), 3.9-4.1 mmol/L (HR: 1.29; CI: 1.08-1.55), 4.8-5.0 mmol/L (HR: 1.34; CI: 1.10-1.63), 5.1-5.5 mmol/L (HR: 1.60; CI: 1.29-1.97), and 5.6-7.4 mmol/L (HR: 3.31; CI: 2.61-4.20) had an increased risk of all-cause mortality. CONCLUSION: Levels within the lower and upper levels of the normal serum potassium range (3.5-4.1 mmol/L and 4.8-5.0 mmol/L, respectively) were associated with a significant increased short-term risk of death in chronic heart failure patients. Likewise, potassium below 3.5 mmol/L and above 5.0 mmol/L was also associated with increased mortality. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Medication prescribed to patients suffering from chronic heart failure carries an increased risk of impaired potassium homeostasis. We examined the relation between different levels of serum potassium and mortality among patients with chronic heart failure. METHODS AND RESULTS: From Danish National registries, we identified 19 549 patients with a chronic heart failure diagnosis who had a measurement of potassium within minimum 90 days after initiated medical treatment with loop diuretics and angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers. All-cause mortality was examined according to eight predefined potassium levels: 2.8-3.4 mmol/L, 3.5-3.8 mmol/L, 3.9-4.1 mmol/L, 4.2-4.4 mmol/L, 4.5-4.7 mmol/L, 4.8-5.0 mmol/L, 5.1-5.5 mmol/L, and 5.6-7.4 mmol/L. Follow-up was 90 days from potassium measurement. We estimated the risk of all-cause mortality using multivariable adjusted Cox proportional hazard model, with normal serum potassium level at 4.2-4.4 mmol/L as reference. After 90 days, the mortality in the eight strata was 14.4, 8.0, 6.3, 5.0, 5.8, 7.9, 10.3, and 21.1% respectively. In multivariable adjusted analysis, patients with potassium levels of 2.8-3.4 mmol/L [hazard ratio (HR): 3.16; confidence interval (CI): 2.43-4.11], 3.5-3.8 mmol/L (HR: 1.62; CI: 1.31-1.99), 3.9-4.1 mmol/L (HR: 1.29; CI: 1.08-1.55), 4.8-5.0 mmol/L (HR: 1.34; CI: 1.10-1.63), 5.1-5.5 mmol/L (HR: 1.60; CI: 1.29-1.97), and 5.6-7.4 mmol/L (HR: 3.31; CI: 2.61-4.20) had an increased risk of all-cause mortality. CONCLUSION: Levels within the lower and upper levels of the normal serum potassium range (3.5-4.1 mmol/L and 4.8-5.0 mmol/L, respectively) were associated with a significant increased short-term risk of death in chronic heart failure patients. Likewise, potassium below 3.5 mmol/L and above 5.0 mmol/L was also associated with increased mortality. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Kevin F O'Sullivan; Mohammad Amin Kashef; Alexander B Knee; Alexander S Roseman; Penelope S Pekow; Mihaela S Stefan; Meng-Shiou Shieh; Quinn R Pack; Peter K Lindenauer; Tara Lagu Journal: J Hosp Med Date: 2019-07-24 Impact factor: 2.960
Authors: Camila Cristiane Toledo; Pedro Vellosa Schwartzmann; Luis Miguel Silva; Gabriel da Silva Ferreira; Fernando Bianchini Cardoso; Vinicius Citelli Ribeiro; Layde Rosane Paim; Lígia M Antunes-Correa; Andrei Carvalho Sposito; Jose Roberto Matos Souza; Rodrigo Modolo; Wilson Nadruz; Luis Sergio Fernandes de Carvalho; Otávio R Coelho-Filho Journal: ESC Heart Fail Date: 2021-03-18
Authors: Pedro Caravaca Perez; José R González-Juanatey; Jorge Nuche; Laura Morán Fernández; David Lora Pablos; Jesús Alvarez-García; Ramón Bascompte Claret; Manuel Martínez Selles; Rafael Vázquez García; Luis Martínez Dolz; Marta Cobo-Marcos; Domingo Pascual Figal; Maria G Crespo-Leiro; Julio Nuñez Villota; Juan Cinca Cuscullola; Juan F Delgado Journal: Clin Res Cardiol Date: 2020-10-17 Impact factor: 5.460